Description
Recombinant monoclonal antibody to Nicotinic acetylcholine alpha4 beta 2 receptor. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 12H2.
Target
Nicotinic acetylcholine alpha4 beta 2 receptor
Target Alias Names
CHRNB2, Nicotinic acetylcholine α4β2 receptor, Neuronal acetylcholine receptor subunit beta-2, human α4β2 nicotinic receptor, AChR
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression